13 Feb 2020 --- Citrus-derived flavonoids supplier Ingredients by Nature (IBN) has gained patent approval for the use of eriocitrin in its ingredient formulations, including Eriomin. The eriocitrin patent claim is stated as “a method of reducing blood glucose levels in a human subject in need thereof, comprising administering to the subject a composition comprising 100 to 200 mg eriocitrin once per day.” The claim will be officially issued in two to three months and published with its accompanying patent number.
